A novel TMPRSS3 missense mutation in a DFNB8/10 family prevents proteolytic activation of the protein
Male
Membrane Proteins/ genetics/metabolism
Chromosomes, Human, Pair 21
Genetic Linkage
DCN 2: Functional Neurogenomics
Molecular Sequence Data
Mutation, Missense
Deafness
03 medical and health sciences
Neoplasm Proteins/ genetics/metabolism
info:eu-repo/classification/ddc/616
UMCN 3.3: Neurosensory disorders
Humans
Deafness/ genetics
Amino Acid Sequence
ddc:616
0303 health sciences
Serine Endopeptidases
Linkage (Genetics)
Membrane Proteins
Neoplasm Proteins
Pedigree
Haplotypes
Serine Endopeptidases/ genetics/metabolism
Female
Lod Score
DOI:
10.1007/s00439-005-1332-x
Publication Date:
2005-07-13T10:36:24Z
AUTHORS (11)
ABSTRACT
Pathogenic mutations in TMPRSS3, which encodes a transmembrane serine protease, cause non-syndromic deafness DFNB8/10. Missense mutations map in the low density-lipoprotein receptor A (LDLRA), scavenger-receptor cysteine-rich (SRCR), and protease domains of the protein, indicating that all domains are important for its function. TMPRSS3 undergoes proteolytic cleavage and activates the ENaC sodium channel in a Xenopus oocyte model system. To assess the importance of this gene in non-syndromic childhood or congenital deafness in Turkey, we screened for mutations affected members of 25 unrelated Turkish families. The three families with the highest LOD score for linkage to chromosome 21q22.3 were shown to harbor P404L, R216L, or Q398X mutations, suggesting that mutations in TMPRSS3 are a considerable contributor to non-syndromic deafness in the Turkish population. The mutant TMPRSS3 harboring the novel R216L missense mutation within the predicted cleavage site of the protein fails to undergo proteolytic cleavage and is unable to activate ENaC, thus providing evidence that pre-cleavage of TMPRSS3 is mandatory for normal function.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (37)
CITATIONS (33)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....